05/21/2024
12:00 PM | MEI Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/28/2024
11:15 PM | MEI Pharma (Filer)
| Form EFFECT | |
02/28/2024
3:04 PM | MEI Pharma (Filer)
| Form 424B5 | |
02/20/2024
4:33 PM | MEI Pharma (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
01/12/2024
3:00 PM | MEI Pharma (Issuer)
Wood Steven D (Reporting)
| Form 4/A | |
01/12/2024
3:00 PM | Flynn James P (Reporting)
MEI Pharma (Issuer)
| Form 4/A | |
12/26/2023
4:00 PM | MEI Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
|
12/22/2023
3:00 PM | MEI Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/20/2023
8:26 PM | MEI Pharma (Issuer)
Wood Steven D (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/20/2023
8:25 PM | Flynn James P (Reporting)
MEI Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/14/2023
7:59 PM | MEI Pharma (Issuer)
Wood Steven D (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
11/09/2023
3:00 PM | MEI Pharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/08/2023
4:03 PM | MEI Pharma (Filer)
| Form DEFA14A | |
11/08/2023
4:04 PM | MEI Pharma (Filer)
| Form ARS | |
11/06/2023
4:06 PM | Datoo Taheer (Reporting)
MEI Pharma (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
11/03/2023
5:04 PM | Flynn James P (Reporting)
MEI Pharma (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
11/01/2023
4:15 PM | Anson Funds Management LP (Filed by)
MEI Pharma (Subject)
| Form DFAN14A | |
11/01/2023
4:20 PM | Anson Funds Management LP (Filed by)
MEI Pharma (Subject)
| Form SC 13D/A | |
11/01/2023
3:54 PM | MEI Pharma (Filer)
| Form DEFA14A | |
10/24/2023
6:32 PM | Anson Advisors Inc. (Reporting)
Anson Funds Management LP (Reporting)
Anson Management GP LLC (Reporting)
Kassam Moez (Reporting)
MEI Pharma (Issuer)
Nathoo Amin (Reporting)
Winson Bruce Ross (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/24/2023
6:34 PM | Cable Car Capital LLC (Reporting)
Funicular Funds, LP (Reporting)
Ma-Weaver Jacob (Reporting)
MEI Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/24/2023
4:00 PM | Anson Funds Management LP (Filed by)
MEI Pharma (Subject)
| Form SC 13D/A | |
10/17/2023
4:28 PM | MEI Pharma (Subject)
| Form DEFC14A | |
10/13/2023
4:00 PM | Anson Funds Management LP (Filed by)
MEI Pharma (Subject)
| Form SC 13D/A | |
10/13/2023
4:02 PM | Anson Advisors Inc. (Reporting)
Anson Funds Management LP (Reporting)
Anson Management GP LLC (Reporting)
Kassam Moez (Reporting)
MEI Pharma (Issuer)
Nathoo Amin (Reporting)
Winson Bruce Ross (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/13/2023
4:04 PM | Cable Car Capital LLC (Reporting)
Funicular Funds, LP (Reporting)
Ma-Weaver Jacob (Reporting)
MEI Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/12/2023
6:38 PM | GHALIE RICHARD G (Reporting)
MEI Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/12/2023
6:39 PM | KANGO SUJAY (Reporting)
MEI Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/12/2023
6:40 PM | MEI Pharma (Issuer)
Reynolds Thomas C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/12/2023
6:40 PM | HOWSON TAMAR D (Reporting)
MEI Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/12/2023
6:41 PM | GOLD DANIEL P PHD (Reporting)
MEI Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/12/2023
6:41 PM | Glover Nicholas (Reporting)
MEI Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/12/2023
6:41 PM | DRISCOLL FREDERICK W (Reporting)
MEI Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/12/2023
6:42 PM | Baltic Charles V. III (Reporting)
MEI Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/12/2023
4:25 PM | MEI Pharma (Filer)
| Form PRER14A | |
10/10/2023
2:00 PM | Anson Funds Management LP (Filed by)
MEI Pharma (Subject)
| Form DFAN14A | |
10/10/2023
9:33 AM | Anson Funds Management LP (Filed by)
MEI Pharma (Subject)
| Form DEFC14A | |
10/03/2023
5:33 AM | MEI Pharma (Filer)
| Form 8-A12B | |
10/03/2023
5:04 AM | MEI Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/02/2023
4:27 PM | MEI Pharma (Filer)
| Form DEFA14A | |
10/02/2023
7:42 AM | Anson Funds Management LP (Filed by)
MEI Pharma (Subject)
| Form PREC14A | |
Shocking $16T Elon Musk Crypto Leak (Ad) Reports of a leaked meeting between Elon Musk and staff at X.com could send shockwaves through the crypto market.
Musk revealed a "mind-blowing" plan to take over the global payment system. In his own words, the world's richest man said "you won't need a bank account."
Prominent voices in crypto believe what comes next will mirror a crypto mass adoption similar to the one that triggered bitcoin's last bull run. Click here now to get your copy. |
09/29/2023
4:13 PM | Anson Funds Management LP (Filed by)
MEI Pharma (Subject)
| Form DFAN14A | |
09/28/2023
4:17 PM | MEI Pharma (Filer)
| Form DEFA14A | |
09/26/2023
4:19 PM | Anson Funds Management LP (Filed by)
MEI Pharma (Subject)
| Form SC 13D/A | |
09/26/2023
4:21 PM | Anson Funds Management LP (Filed by)
MEI Pharma (Subject)
| Form DFAN14A | |
09/26/2023
3:31 PM | MEI Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/26/2023
3:11 PM | MEI Pharma (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
09/26/2023
2:42 PM | Anson Funds Management LP (Filed by)
MEI Pharma (Subject)
| Form DEFC14A | |
09/25/2023
6:41 PM | Cable Car Capital LLC (Reporting)
Funicular Funds, LP (Reporting)
Ma-Weaver Jacob (Reporting)
MEI Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/25/2023
6:43 PM | Anson Advisors Inc. (Reporting)
Anson Funds Management LP (Reporting)
Anson Management GP LLC (Reporting)
Kassam Moez (Reporting)
MEI Pharma (Issuer)
Nathoo Amin (Reporting)
Winson Bruce Ross (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/22/2023
8:19 PM | Cable Car Capital LLC (Reporting)
Funicular Funds, LP (Reporting)
Ma-Weaver Jacob (Reporting)
MEI Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/22/2023
8:21 PM | Anson Advisors Inc. (Reporting)
Anson Funds Management LP (Reporting)
Anson Management GP LLC (Reporting)
Kassam Moez (Reporting)
MEI Pharma (Issuer)
Nathoo Amin (Reporting)
Winson Bruce Ross (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/22/2023
4:21 PM | Anson Funds Management LP (Filed by)
MEI Pharma (Subject)
| Form SC 13D/A | |
09/22/2023
4:24 PM | Anson Funds Management LP (Filed by)
MEI Pharma (Subject)
| Form DFAN14A | |
09/21/2023
7:12 PM | Klarquist Scott (Filed by)
MEI Pharma (Subject)
| Form PX14A6G | |
09/18/2023
3:16 PM | MEI Pharma (Filer)
| Form DEFA14A | |
09/18/2023
8:29 AM | MEI Pharma (Subject)
| Form PREC14A | |
09/15/2023
4:29 PM | Anson Funds Management LP (Filed by)
MEI Pharma (Subject)
| Form SC 13D/A | |
08/04/2023
4:15 PM | Anson Funds Management LP (Filed by)
MEI Pharma (Subject)
| Form PRRN14A | |
08/01/2023
6:07 PM | File Justin J. (Reporting)
MEI Pharma (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
07/27/2023
4:27 PM | MEI Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/24/2023
8:16 AM | MEI Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/19/2023
3:35 PM | Anson Funds Management LP (Filed by)
MEI Pharma (Subject)
| Form DFAN14A | |
07/18/2023
4:26 PM | MEI Pharma (Subject)
| Form 425 | |
07/18/2023
4:20 PM | MEI Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/17/2023
3:34 PM | Anson Funds Management LP (Filed by)
MEI Pharma (Subject)
| Form SC 13D/A | |
07/17/2023
3:34 PM | Anson Funds Management LP (Filed by)
MEI Pharma (Subject)
| Form DFAN14A | |
07/17/2023
3:02 PM | MEI Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/17/2023
3:03 PM | MEI Pharma (Subject)
| Form 425 | |
07/17/2023
8:15 AM | Anson Funds Management LP (Filed by)
MEI Pharma (Subject)
| Form PREC14A | |
07/13/2023
3:19 PM | MEI Pharma (Filer)
| Form 424B3 | |
07/13/2023
3:15 PM | MEI Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/13/2023
3:17 PM | MEI Pharma (Subject)
| Form 425 | |
07/10/2023
8:10 AM | Klarquist Scott (Filed by)
MEI Pharma (Subject)
| Form PX14A6G | |
07/07/2023
3:51 PM | MEI Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/03/2023
3:56 PM | MEI Pharma (Filer)
| Form 424B3 | |
06/28/2023
5:07 AM | MEI Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/28/2023
5:09 AM | MEI Pharma (Subject)
| Form 425 | |
06/20/2023
5:11 AM | MEI Pharma (Subject)
| Form 425 | |
06/20/2023
5:08 AM | MEI Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/13/2023
8:28 PM | MEI Pharma (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
06/13/2023
3:01 PM | MEI Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/13/2023
3:10 PM | MEI Pharma (Subject)
| Form 425 | |
06/06/2023
11:15 PM | MEI Pharma (Filer)
| Form EFFECT | |
06/06/2023
3:37 PM | MEI Pharma (Issuer)
Urso David M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/02/2023
7:54 PM | MEI Pharma (Filer)
| Form S-4/A | |
06/02/2023
7:15 AM | MEI Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/02/2023
7:20 AM | MEI Pharma (Subject)
| Form 425 | |
06/01/2023
7:16 AM | MEI Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/01/2023
7:22 AM | MEI Pharma (Filer)
| Form DEFA14A | |
